Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.
A new omicron Covid subvariant is circulating as the U.S. is poised to roll out new vaccines this fall. The subvariant, named Eris, makes up about 17% of cases in the U.S.
The new jabs have been developed to target the XBB.1.5 subvariant, but they are still expected to protect against Eris, which has a similar genetic makeup.
Right now, Eris doesn’t appear to cause more serious illness than other omicron subvariants.
In other health news, blockbuster weight-loss drugs are priced significantly higher in the U.S. compared to other countries, according to a new KFF study.
And a federal appeals court ruled that restrictions should be imposed on how the abortion pill mifepristone is used and distributed.
The ruling is on pause for now as the case is poised for the Supreme Court.
Feel free to send any tips, suggestions, story ideas and data to me at spencer.kimball@nbcuni.com.
